Americans are increasingly using herbs and herbal preparations to treat a wide array of conditions ranging from colds to depression. Children and parents are ingesting herbs in greater quantities, as reflected by increased herb sales and telephone calls to poison information centers. Herbal preparations are being used for the management of insomnia, anxiety, and attention deficit hyperactivity disorders. This trend introduces interesting opportunities and dilemmas for the school nurse. This article provides an overview of the seven most common medicinal herbs (garlic, ginkgo, ginseng, Echinacea, chamomile, valerian, and feverfew). It provides a guide to choosing herbal supplements, a framework for developing school-based herbal policies, and a discussion of the issues faced by school nurses.
A thru Z herbal Rx. (1999). The promise and pitfallsConsumer Reports64(3), 44–48.
2.
BalmerC. (1998). Alternative therapies in cancer patient care.Highlights of Oncology Practice,15, 83–84.
3.
BerholdH. K., SudhopT., & von BergmannK. (1998). Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: A randomized controlled trial.Journal of the American Medical Association,279, 1900–1902.
4.
BlumenthalM., BrusseW. R., GoldbertA., GruenwaldJ., HallT., RigginsC. W., & RisterR. S. (1998). The complete German commission E monographs.Austin, TX: American Botanical Council.
5.
ChavezM. L., & ChavezP. I. (1998). Monographs on alternative therapies: Echinacea.Hospital Pharmacy,33, 180–188.
6.
ChavezM. L., & ChavezP. I. (1997). Monographs on alternative therapies: Saint John's Wort.Hospital Pharmacy,32, 1621–1632.
7.
Dupont Pharmaceuticals. (1997). Interactions—Warfarin and herbal products. Wilmington, DE: Dupont Pharmaceuticals Professional Services.
8.
ErnstE. (1998). Harmless herbs? A review of the recent literature.American Journal of Medicine,104, 70–78.
9.
Food and Drug Administration. (1997, November). FDA warns against drug promotion of “herbal fen-phen”. FDA talk paper. Retrieved December 6, 1997, from the World Wide Web: http://www.fda.gov/bbs/topics/answers/ans00832.html
10.
Food and Drug Administration.FDA warns consumers about dietary supplements containing digitalis. FDA talk paper. Retrieved from the World Wide Web: http://www.fda.gov/bbs/topics/NEWS/NEWS00570.html
11.
Fugh-BermanA. (1997). Clinical trials of herbs. Primary care.Clinics in Office Practice,24, 889–903.
12.
JohnsonS. T., & WordellC.J. (1997). Homeopathic and herbal medicine: Considerations for formulary evaluation.Formulary,32, 1166–1173.
13.
LeadersF. E. (1998). Incorporating botanical products into MCO formularies.Drug Benefit Trends,10, 34, 36–39,-43.
14.
LeBarsP. L., KatzM. M., BermanN., ItilT. M., FreedmanA. M., & SchatzbergA. F. (1997). A placebo-controlled, double-blind randomized trial of an extract of Ginkgo biloba for dementia. The North American EGb Study Group. Journal of the American Medical Association,278, 1327–1332.
15.
MatthewsM. K. (1998). Association of ginkgo biloba with intracerebral hemorrhage.Neurology,50, 1933–1934.
Practice and Policy Guideline Panel. (1997). National Institutes of Health Office of Alternative Medicine. Clinical practice guidelines in complementary and alternative medicine: An analysis of opportunities and obstacles.Archives of Family Medicine,6, 149–154.
18.
RoseK. D., CroissantP. D., ParliamentC. R, & LevinM. B. (1990). Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: A case report.Neurosurgery,26, 880–882.
19.
RosenblattM, & MindelJ. (1997). Spontaneous hyphema associated with ingestion of Ginkgo biloba extract [Letter].New England Journal of Medicine,336, 1108.
20.
StevermerJ. J., & LindbloomE. J. (1998). Ginkgo biloba for dementia.Journal of Family Practice,46, 20.
21.
SunterW. H. (1991). Warfarin and garlic [Letter to the editor].Pharmacology,246, 722.
22.
TylerV. E. (1996). What pharmacists should know about herbal remedies: Pharmacists can help patients differentiate the useful herbs from the harmful ones.Journal of the American Pharmaceutical Association, NS36, 29–37.
23.
U.S. Department of Health and Human Services [DHHS]. (1999) Vital and health statistics. Use of dietary supplements in the United States, 1988–94. Hyattsville, MD: DHHS. Publication 99–1694.
24.
ValeS. (1998). Subarachnoid haemorrhage associated with Ginkgo biloba.Lancet,352, 36.
